CVD Risk Up With β2-Agonist, Antimuscarinic Antagonist Start
New use of long-acting β2-agonists, antimuscarinic antagonists tied to higher CVD risk in first 30 days
Silent Myocardial Infarction Linked to Heart Failure Risk
Silent and clinically manifested MI both correlated with future risk of heart failure in adjusted models
Higher Risk of Musculoskeletal Disorders in Some Physicians
Increasing risk for work-related musculoskeletal disorders, particularly in procedural specialists
December 2017 Briefing – Pulmonology
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for December 2017. This roundup includes the latest...
Pre-Op Accelerometry Can Assess Cardiopulmonary Fitness
Accelerometry variables correlate with cardiopulmonary exercise variables
Fractional Exhaled NO Moderately Accurate to Diagnose Asthma
FeNO measurement performs better in diagnosing non-smokers, children, and steroid-naive patients
Pharmaceutical Aids Not Found to Be Helpful for Smoking Cessation
No evidence that varenicline, bupropion, or nicotine replacement increase probability of abstinence
Out-of-Pocket Costs Correlate With Receipt of Cancer Care
Across cancers, higher costs tied to higher rates of oral prescription abandonment, delayed initiation
Sleep May Mediate Fish-Cognition Relationship in Children
Sleep quality partially mediates relationship between fish consumption and verbal IQ in children
Guidelines Developed for Optimizing Treatment of HFrEF
Consensus statement addresses 10 pivotal issues in heart failure with reduced ejection fraction
